Thomas Marbury, MD
Orlando Clinical Research Center
11
11
11
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+4 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (11)
Showing 10 of 11 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Hans A Eriksson, MD
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Mark Sostek, MD
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
William Smith, MD
New Orleans Clinical Center for Research
Shared therapeutic areas:
Worked with same sponsors:
Salvatore Febbraro, MD
Simbec Research
Shared therapeutic areas:
Worked with same sponsors:
Suzanne Swann, MD
Davita Clinical Research
Shared therapeutic areas:
Worked with same sponsors:
Bo Fransson, MD
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Richard Preston, MD
University of Miami
Shared therapeutic areas:
Worked with same sponsors:
Eric Lawitz, MD
American Research Corporation at the Texas Liver Institute
Shared therapeutic areas:
Worked with same sponsors:
James Longstreth, PhD
USWM, LLC (dba US WorldMeds)
Shared therapeutic areas:
Worked with same sponsors:
George Wu, MD
University of Connecticut
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (11)
Showing 11 of 11 trials
A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment
Phase 1 PK Study to Evaluate the PK of CIN-107 in Subjects With Hepatic Impairment
Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients
Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects
Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246
A Study of Fostamatinib in Subjects With Impaired Hepatic (Liver) Function
To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function
Open-label Study to Assess the Pharmacokinetics of NKTR-118 in Patients With Impaired Hepatic Function
A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy Subjects
Single-Dose Pharmacokinetics and Safety of Oral Lofexidine in Hepatically-Impaired Subjects
All 11 trials loaded